Home › NDC Lookup › RxCUI directory › RxCUI 393245

Digoxin 0.05 MG/ML Oral Solution — RxCUI 393245

RxNorm drug concept · Semantic clinical drug
RxCUI 393245 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI393245
Official nameDigoxin 0.05 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdigoxin 50 MCG/ML Oral Solution; digoxin 0.05 MG in 1 mL Oral Solution; digoxin 50 MCG per 1 ML Oral SOlution
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)7,671 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Digoxin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats mild to moderate heart failure in adults and helps control the heart rate in chronic atrial fibrillation. It is also used in children with heart failure. It can ease symp...
  • Take it exactly as your prescriber directs, at about the same time each day. Tablets can be taken with or after meals, but try to be consistent. Avoid high-bran meals around your d...
  • Nausea, vomiting, loss of appetite, diarrhea, dizziness, headache and tiredness are among the more common ones. Call me or your doctor if you notice vision changes like blurred or...
  • Many medicines interact with digoxin. Heart rhythm drugs, some antibiotics and antacids are common examples, and St. John’s Wort can lower digoxin levels. Always check with me befo...
📖 Read our full Digoxin guide →

🕸️ Concept Web — How Digoxin 0.05 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Digoxin 0.05 MG/ML Oral Solution RxCUI 393245

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Digoxin 3407
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Digoxin Oral Solution 371833
    • Digoxin Oral Liquid Product 1151520
    • Digoxin Oral Product 1151521
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Digoxin 0.05 MG/ML 315817

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Digoxin 0.05 MG/ML SCDC · 315817
  • Digoxin Oral Solution SCDF · 371833
  • Digoxin Oral Liquid Product SCDG · 1151520
  • Digoxin Oral Product SCDG · 1151521

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 393245 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0057-46 60 mL in 1 BOTTLE (0054-0057-46) Digoxin Hikma Pharmaceuticals USA Inc. 2004-08-26
17856-0057-01 2.5 mL in 1 CUP, UNIT-DOSE (17856-0057-1) Digoxin Atlantic Biologicals Corps 2011-12-05
17856-0057-05 5 mL in 1 CUP (17856-0057-5) Digoxin Atlantic Biologicals Corps 2018-09-24
66689-0327-02 1 BOTTLE, GLASS in 1 CARTON (66689-327-02) / 60 mL in 1 BOT... Digoxin VistaPharm, LLC 2019-10-04
69292-0605-60 1 BOTTLE in 1 CARTON (69292-605-60) / 60 mL in 1 BOTTLE Digoxin Amici Pharma, Inc 2022-06-10
Observed labelers: Atlantic Biologicals Corps (2) · Amici Pharma, Inc (1) · Hikma Pharmaceuticals USA Inc. (1) · VistaPharm, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.1184
Range $1.1184–$1.1184 · middle 50% $1.1184–$1.1184 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.